myTomorrows

Today is World Mental Health Day! ☀️ This year’s theme from the @World Health Organization is Mental Health at Work and highlights the important connection between mental well-being and productivity at work. In support, this week we’ve arranged series of activities for our Mighty Mighties, designed to promote connection, reflection and support within our team. 🌠 Here’s what’s in store… mindful exercises and guided meditation, creative spaces and opportunities to open up conversations in a safe and supportive space. 👏 Check out this photo of the team who took part in one of the activities to de-stress and reconnect! 💞 Fostering positive mental health both at work and in our private lives is incredibly important at myTomorrows and we’re committed to doing all we can to help and support staff to find a comfortable balance. 💪 #WorldMentalHealthDay #MentalHealthAtWork #MentalWellbeing #WorkplaceWellness #myTomorrows

Exciting News! 🚀 We are thrilled to announce that myTomorrows has been nominated for the Deloitte Technology Fast 50 2024 Award! This recognition as one of the 50 fastest-growing technology companies in the Netherlands is a true testament to the dedication, innovation, and hard work of our entire team. 👏 But that’s not all – we’re also very excited to be nominated for the Diverse & Inclusive Leadership Award. Promoting inclusivity and fostering a diverse workplace has always been key at myTomorrows, and being acknowledged for these efforts is truly an honor! ☀️ We can’t wait to see where we land in the final Fast 50 ranking, which will be revealed at the award show on November 7th. A big thank you to everyone who has supported us on this journey! 🌟 Stay tuned for the results! #Fast50 #TechnologyFast50 #DiversityAndInclusion #Innovation #Teamwork #Gratitude #myTomorrows

We’re live at the 3rd Operationalise: Early Access Programmes Summit Europe and excited to contribute to the discussions with industry partners on improving patient access through Early Access Programmes!🚀 Today at 3:30 PM BST, don’t miss our fireside chat for industry members on Supporting Pediatric Patient Populations: The Case for Expanded Access, where our very own Natalia Coptu and Karlijn Doorn, PhD will be joined by Dr. Uri Ilan (Prinses Maxima Centrum) and Anke Friedetzky (Pierre Fabre Group) to discuss about how to better support access for pediatric patient populations. Key takeaways will include: ✔️Understanding treatment gaps in pediatric care and how EAPs can bridge them ✔️Engaging with key stakeholders involved in pediatric Expanded Access ✔️Practical strategies from real-world case studies See you at 3:30 pm BST! ☀️ #EAPs #Globalregulations #ExpandedAccess #BioPharm #MedicalAccess

💼 Ready to make Mondays more meaningful? Dive into our latest job listings today. Become a part of our dynamic group of Mighties with diverse backgrounds in Medical, Pharma, Tech, and Business. This is an exciting opportunity to join our ambitious company as it grows. With benefits like flexible working, a learning and development budget, and an annual performance bonus, you’ll be based in Amsterdam with a fast-growing company of 80+ people, with 30 nationalities, helping patients to know all their treatment options. 💚 Senior Backend Engineer https://lnkd.in/epdU-N9M Patient Navigator (in Mexico) https://lnkd.in/eaDWyfxj Patient Navigator (in India) https://lnkd.in/eHjFmcca Our full list: https://lnkd.in/eTgxyuhn   #WeAreMighty #newjob #hiring

Happening TODAY! 🚀 The day is finally here! Join us today, October 3rd at 1:30pm EST/7:30pm CEST, for our much-anticipated panel discussion: "Unlocking LGMD2I Clinical Trials: A Patient and Caregiver’s Guide to Participating." ☀️ Our session will offer practical guidance on locating, accessing, and participating in clinical trials for those with Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I), and an overview of all currently available clinical trials. 👥 Our expert panel features Kelly Brazzo (CEO of CureLGMD2i Foundation and LGMD patient caregiver/mother), Kat Bryant Knudson (Speak Foundation), Melissa Grove (LGMD Patient Advocate), and Terri Ellsworth (Patient Advocacy Liaison). Moderated by Dennis Akkaya (CCO at myTomorrows), this discussion will offer you insights into the current landscape of LGMD2I clinical trials. What you will learn: ✔️Gain a clear understanding of clinical trials and their role in LGMD2I treatments. ✔️Receive practical guidance on how to find and access information on clinical trials, including how to make informed decisions together with your healthcare providers. ✔️Learn key information on active LGMD2I clinical trials, including eligibility criteria and enrolment steps. ➡️ It’s not too late to join us! Register now and be part of this insightful discussion. https://lnkd.in/eci4KaMA We look forward to seeing you today! #LGMD2I #ClinicalTrials #HealthcareProfessionals #PAGs #PatientAdvocacy #RareDisease

We're excited to share that our Chief Commercial Officer, Dennis Akkaya, and Kelly Brazzo, CEO of the CureLGMD2i Foundation, were featured in an insightful interview in NeurologyLive! They talked about our new partnership, which aims to make clinical trials discovery more accessible for patients with Limb-Girdle Muscular Dystrophy (LGMD), a rare genetic condition characterized by progressive weakness and wasting of the muscles.🚀 🔬Currently, several new investigational treatments for LGMD, including gene therapy, are being studied in clinical trials. In the interview, Dennis and Kelly talked about the challenges faced by those LGMD patients seeking information about clinical trials to learn about their options. Publicly available information, such as online databases or public registries, can be overwhelming and hard to navigate for these patients. Additionally, since many trials target specific subtypes, patients who aren’t sure of their exact subtype can struggle to find the right match. As a result, many of these patients are left confused, unsure of which trials are available, whether they qualify, and how to enroll. 👏 Dennis and Kelly discussed how our partnership aims to address these issues by creating a more patient-friendly way to find relevant clinical trials. Through myTomorrows’ search engine, patients and physicians can more easily access global trial options, while patient navigators offer guidance and support throughout the journey, helping individuals make informed decisions with their physicians about their care.🌠 Together, we are committed to building a safe and reliable space where patients can ask questions and understand their options.☀️ Read the full interview here: https://lnkd.in/eRSk9UGW #LGMD #ClinicalTrials #RareDisease #NeurologyLive #Partnership #PatientCare #HealthTech #DrugDevelopment

Exciting News!☀️ Our very own Dennis Akkaya, Karlijn Doorn, PhD, Daniele Tagliente, Natalia Coptu and Sarah Gunson are thrilled to attend the 3rd Operationalise: Early Access Programmes Summit Europe in just a few days! 🚀 This premier European forum for industry partners will explore key topics such as global regulations and the evolving landscape of Early Access Programmes (EAPs). The summit will cover important points such as creating unified regulatory guidelines and finding the best types of data for research and compliance. Our Mighties cannot wait to learn more about it and build new connections within the #EAP space! ➡️ We are also excited to host a fireside chat “Supporting Pediatric Patient Populations: The Case for Expanded Access” on 8th October at 3:30pm-4:00pm. During this industry expert session, we will talk about how to better support access for pediatric patient populations. Participants will learn about: ✔️The critical treatment gaps in pediatric care and how Expanded Access Programs can bridge these gaps to improve patient outcomes. ✔️Recognize how to navigate and engage with key stakeholders involved in pediatric Expanded Access requests. ✔️Gain practical insights from real-world Expanded Access case studies, offering actionable strategies for implementing pediatric access initiatives. Looking forward to seeing you there! Stay tuned for more updates during the event.🌠 #EAPs #Globalregulations #ExpandedAccess #BioPharm #MedicalAccess

At myTomorrows, we're proud to be supporting our partner brainstrust with their #WearGrey community campaign, a powerful initiative dedicated to raising awareness about brain tumours. 🎗️ This movement is about more than just wearing grey—it's about standing in solidarity with patients, caregivers, and everyone impacted by brain tumours. Together, we are amplifying the voices of those affected, championing research, and striving for better access to treatments. 💪🧠 We’ve recently launched a new patient resource page dedicated to providing patients and loved ones with helpful information about brain tumours – explore more here: https://lnkd.in/ezK8qFBx So this week, join us in this meaningful cause, #WearGrey and together we can raise awareness for #BrainTumourAwareness

⚽ Kick off your weekly job search with us. We are looking for three #ambitious people to help deliver a whole new approach to enabling earlier access to all possible treatment options, making a #MightyImpact on many lives. Share our job openings with your network who may be interested, and they could join a fast-growing company of 80+ people, with 30 nationalities, offering great benefits in Amsterdam. ✔️Backend engineer https://lnkd.in/e-rKjhbA ✔️Senior Backend Engineer https://lnkd.in/e8MwX8Xh ✔️Patient Navigator (Mexico) https://lnkd.in/eF8raeyb Our full list: https://lnkd.in/eQVEyMjm   #WeAreMighty #newjob #hiring

🌍 Today is Limb-Girdle Muscular Dystrophy (LGMD) Awareness Day, and at myTomorrows, we are proud to stand with the #LGMD community. Limb-girdle muscular dystrophy refers to a group of diseases that cause weakness and wasting of the muscles, specifically muscles of the shoulders, upper arms, pelvic area, and thighs. Estimates suggest that it affects around 0.8 to 6 people per 100,000 individuals worldwide. At myTomorrows, we work to help people with rare diseases like LGMD to discover and access treatments. To further drive awareness and provide support directly to the LGMD2i community, on Thursday we’re hosting an informative webinar with CureLGMD2i Foundation and Speak Foundation, which looks at ‘Unlocking LGMD2i Clinical Trials: A Patient and Caregiver’s Guide to Participating.’ This panel discussion will provide people with Limb-Girdle Muscular Dystrophy Type 2i (LGMD2i), as well as their families and caregivers, with information about navigating the clinical trial landscape. If you or a loved one are living with limb-girdle muscular dystrophy, you’d be very welcome to register and join us. https://lnkd.in/earzQ-NH Let's continue together to raise awareness and drive meaningful change. 💪 #LGMDAwareness #RareDisease #PatientSupport